• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 08/19/2017
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Medical

  • 2:16 PM

    Viaderma, Inc. announces Galaxy Solutions, Inc. as new sales representative for select Asia Pacific markets LOS ANGELES, CA, VDRM, –(Marketwired – August 18, 2017) – ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, announced today that it has appointed Galaxy Solutions, Inc. as its sales representative for its first aid topical antibiotic which will be sold under the brand name Vitastem in select markets of Asia Pacific, starting in Japan. The agreement includes sales and

    Read more
  • 12:04 PM

    Conference call begins at 11:00 a.m. Eastern time tomorrow August 15 MINNEAPOLIS, Aug. 14, 2017, SKLN, (GLOBE NEWSWIRE) — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications (“STREAMWAY”), reports financial results for the three and six months ended June 30, 2017 and provides a business update. Highlights of the second quarter of 2017 and recent weeks include: Signed a definitive agreement to merge with CytoBioscience Received CE mark for the STREAMWAY

    Read more
  • 11:37 AM

    Audit to prepare for eventual sales into the US market SALT LAKE CITY–CODX, (BUSINESS WIRE)– Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, will be undergoing a Stage II Upgrade Assessment Audit to ISO 13485:2016. The International Organization of Standards (ISO) is a non-government entity comprised of academic and industry professionals which certifies that companies are compliant with industry-standard best practices in their production and operations.

    Read more
  • 11:22 AM

    Molecular Test Now Covered for Indeterminate Thyroid Nodules PARSIPPANY, N.J., July 27, 2017, IDXG, (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services for improved patient diagnosis and management, announced today that Cigna, one of the largest national health plans in the United States, has agreed to cover Interpace’s ThyGenX® test for Cigna’s 15 million members nationwide, with coverage effective immediately.  Cigna’s

    Read more
  • 12:26 PM

    SALT LAKE CITY–CODX, (BUSINESS WIRE)– Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced today the recent incorporation of CoSara Diagnostics, Pvt., Ltd., a Joint Venture for manufacturing with Synbiotics Limited. Synbiotics is a group company of Asence Inc, a U.S. incorporated company specializing in supplying pharmaceutical products to international markets. Co-Diagnostics and Synbiotics incorporated the CoSara entity in India in July. Co-Diagnostics paid

    Read more
  • 10:22 AM

    Company achieves milestone of its first U.S. regulatory filing for a medical device FRAMINGHAM, MA–ARTH, (Marketwired – Jul 25, 2017) – Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced that the Company made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its AC5™ Topical Gel on July 17, 2017. If the Company’s 510(k) application is cleared by the FDA, it is expected

    Read more
Public Wire Banner